# Mild and moderate COVID-19 during Alpha, Delta and Omicron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022: A population-based surveillance study

**Authors:** Brecht Ingelbeen, Victória Cumbane, Ferão Mandlate, Barbara Barbé, Sheila Mercedes Nhachungue, Nilzio Cavele, Cremildo Manhica, Catildo Cubai, Neusa Maimuna Carlos Nguenha, Audrey Lacroix, Joachim Mariën, Anja de Weggheleire, Esther van Kleef, Philippe Selhorst, Marianne A. B. van der Sande, Martine Peeters, Marc-Alain Widdowson, Nalia Ismael, Ivalda Macicame, Nei-yuan (Marvin) Hsiao, Nei-yuan (Marvin) Hsiao

PMC · DOI: 10.1371/journal.pgph.0003550 · PLOS Global Public Health · 2024-08-05

## TL;DR

This study tracked mild and moderate COVID-19 cases in urban Mozambique during the Alpha, Delta, and Omicron waves, finding frequent underreporting and no link between poverty and higher infection risk.

## Contribution

The study provides novel insights into the impact of established risk factors on mild/moderate COVID-19 in sub-Saharan Africa.

## Key findings

- 364.5 respiratory illness episodes per 1000 person-years, with 72.2 being COVID-19.
- Seroprevalence increased from 4.8% in December 2020 to 34.7% in June 2021.
- Older age, chronic lung disease, hypertension, and overweight increased the risk of COVID-19.

## Abstract

In sub-Saharan Africa, reported COVID-19 numbers have been lower than anticipated, even when considering populations’ younger age. The extent to which risk factors, established in industrialised countries, impact the risk of infection and of disease in populations in sub-Saharan Africa, remains unclear. We estimated the incidence of mild and moderate COVID-19 in urban Mozambique and analysed factors associated with infection and disease in a population-based surveillance study. During December 2020-March 2022, 1,561 households (6,049 participants, median 21 years, 54.8% female, 7.3% disclosed HIV positive) of Polana Caniço, Maputo, Mozambique, were visited biweekly to report respiratory symptoms, anosmia, or ageusia, and self-administer a nasal swab for SARS-CoV-2 testing. Every three months, dried blood spots of a subset of participants (1,412) were collected for detection of antibodies against SARS-CoV-2 spike glycoprotein and nucleocapsid protein. Per 1000 person-years, 364.5 (95%CI 352.8–376.1) respiratory illness episodes were reported, of which 72.2 (95%CI 60.6–83.9) were COVID-19. SARS-CoV-2 seroprevalence rose from 4.8% (95%CI 1.1–8.6%) in December 2020 to 34.7% (95%CI 20.2–49.3%) in June 2021, when 3.0% were vaccinated. Increasing age, chronic lung disease, hypertension, and overweight increased risk of COVID-19. Older age increased the risk of SARS-CoV-2 seroconversion. We observed no association between socio-economic status, behaviour and COVID-19 or SARS-CoV-2 seroconversion. Active surveillance in an urban population confirmed frequent COVID-19 underreporting, yet indicated that the large majority of cases were mild and non-febrile. In contrast to reports from industrialised countries, social deprivation did not increase the risk of infection nor disease.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** N (nucleocapsid phosphoprotein) [NCBI Gene 43740575]
- **Diseases:** febrile (MESH:D000071072), ageusia (MESH:D000370), lung disease (MESH:D008171), infection (MESH:D007239), anosmia (MESH:D000857), overweight (MESH:D050177), COVID-19 (MESH:D000086382), respiratory symptoms (MESH:D012818), hypertension (MESH:D006973), respiratory illness (MESH:D012140), HIV (MESH:D015658)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11299809/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11299809/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11299809/full.md

---
Source: https://tomesphere.com/paper/PMC11299809